These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [A large amount of distilled water ineffective for prevention of bladder cancer cell implantation at the time of transurethral resection]. Sakai Y; Fujii Y; Hyochi N; Masuda H; Kawakami S; Kobayashi T; Kageyama Y; Kihara K Hinyokika Kiyo; 2006 Mar; 52(3):173-5. PubMed ID: 16617868 [TBL] [Abstract][Full Text] [Related]
66. [Long-term results and complications of intravesical instillation of bacillus Calmette-Guerin for prophylaxis of bladder cancer recurrence]. Irie A; Lee KE; Kadowaki K; Sawamura M Hinyokika Kiyo; 1994 Oct; 40(10):873-7. PubMed ID: 7992700 [TBL] [Abstract][Full Text] [Related]
67. Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer. Zang Z; Xu H; Yu L; Yang D; Xie S; Shi Y; Li Z; Li J; Wang J; Li M; Guo Y; Gu F Chin Med J (Engl); 2000 Nov; 113(11):1002-6. PubMed ID: 11776112 [TBL] [Abstract][Full Text] [Related]
68. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report. Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708 [TBL] [Abstract][Full Text] [Related]
69. The FISH test for the diagnosis, surveillance, and prognosis of transitional cell carcinoma of the bladder. Haddad FS J Med Liban; 2008; 56(4):230-2. PubMed ID: 19115598 [TBL] [Abstract][Full Text] [Related]
70. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. Okamura T; Tozawa K; Yamada Y; Sakagami H; Ueda K; Kohri K J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375 [TBL] [Abstract][Full Text] [Related]
71. [Prevention of local recurrences in recurring, non-invasively growing bladder cancer. Preliminary report]. Lutherer S; Cranidis A; Terhorst B Helv Chir Acta; 1982 Aug; 49(3-4):357-9. PubMed ID: 7129900 [No Abstract] [Full Text] [Related]
72. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer]. Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430 [TBL] [Abstract][Full Text] [Related]
74. Acute nonlymphocytic leukemia following bladder instillations with thiotepa. Easton DJ; Poon MA Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320 [TBL] [Abstract][Full Text] [Related]
75. [Long-term results of intravesical N-CWS instillation to prevent recurrence after surgery for bladder cancer]. Chen S; Lin Z; Xu E Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):228-30. PubMed ID: 10920905 [TBL] [Abstract][Full Text] [Related]
76. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG]. Wetzel O; Glemain P; Bouchot O; Guillonneau B; Baron M; Buzelin JM; Auvigne J Prog Urol; 1993; 3(4):595-607. PubMed ID: 8401620 [TBL] [Abstract][Full Text] [Related]
77. [Intravesical instillation in the treatment of superficial tumors of the bladder]. Chopin DK Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941 [TBL] [Abstract][Full Text] [Related]